CMS sticks to its guns, limiting coverage of Biogen’s Aduhelm to clinical trials
CMS sticks to its guns, limiting coverage of Biogen’s Aduhelm [...]
Despite TV ads, most asthma patients don’t recognize new biologic brands, but they’re willing to try them, a survey finds
Despite TV ads, most asthma patients don’t recognize new biologic [...]
Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers Squibb may struggle: analysts
Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers [...]
AAN: AstraZeneca touts new Ultomiris gMG data ahead of potential Argenx showdown
AAN: AstraZeneca touts new Ultomiris gMG data ahead of potential [...]
Amgen gives CEO a pay bump despite its eventful year ending in stagnant revenue
Amgen gives CEO a pay bump despite its eventful year [...]
GSK, Vir’s COVID antibody put on ice as BA.2 subvariant takes hold
GSK, Vir’s COVID antibody put on ice as BA.2 subvariant [...]
BioNTech CEO’s pay fell last year, but he’s still a billionaire thanks to holdings in mRNA specialist
BioNTech CEO’s pay fell last year, but he’s still a [...]
ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk patients
ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk [...]
Sanofi, Regeneron score fast FDA review for Dupixent in eosinophilic esophagitis
Sanofi, Regeneron score fast FDA review for Dupixent in eosinophilic [...]
Alnylam’s Onpattro follow-on delayed thanks to manufacturing holdup at FDA
Alnylam’s Onpattro follow-on delayed thanks to manufacturing holdup at FDA [...]